American Society of Hirudotherapy

Transparency & Trust

How ASH operates \u2014 governance, editorial integrity, and the receipt-trail behind every claim.

Last Updated: May 27, 2026Reviewed by: Andrei Dokukin, MD
Institutional transparency referenceAuditable & public

Hirudotherapy occupies a regulatory edge case in U.S. medicine: an FDA-cleared medical device that's also been the subject of fringe claims. Patients and clinicians need to know: can I trust this site?

This page lays out the structural answer. Not promises \u2014 receipts.

Five pillars of trust

1. Legal & tax status

ASH is a California 501(c)(3) nonprofit (EIN 92-2997844). Tax-exempt status anchors fiduciary responsibility and prevents revenue-driven editorial bias.

  • Registered in California, USA
  • EIN 92-2997844 publicly verifiable via IRS Tax-Exempt Organization Search
  • Annual reports publicly available
Annual report →

2. Editorial independence

Editorial decisions are decoupled from supplier relationships, donor influence, and commercial interest. No paid product placements. No paid testimonials. No affiliate revenue on the site.

  • Editorial board with documented credentials
  • Conflict-of-interest disclosures per contributor
  • No advertising on the site
Editorial policy →

3. Source verification

Every PMID cited is verified against PubMed. Three fabricated PMIDs were caught and corrected in May 2026 \u2014 logged publicly, not silently revised.

  • PMID = link to NCBI National Library of Medicine record
  • DOI fallback when PMID unavailable
  • FDA 510(k) summary linked for Tier A claims
  • Three-tier evidence framework on every clinical page
How evidence is graded →

4. Public corrections

When errors are found, they are corrected publicly with a changelog entry \u2014 not silently revised. Every commit is on public GitHub.

  • Public changelog with PR-level granularity
  • Errata page for substantive content corrections
  • Full git history on GitHub
Public changelog →

5. Open infrastructure

The entire content layer is open. The structured registries (conditions, compounds, RCTs, biographies, jurisdictions) and the source code that renders the site are public. Researchers can fork, propose changes, and audit the data layer directly.

  • Source code on GitHub (RondvS/ash-website)
  • Registry data in lib/*-registry.ts \u2014 readable, queryable, exportable
  • Public PR queue with peer review on every substantive change
  • Long-term: machine-readable API for researchers (Phase 4)
Research roadmap →

What you can verify yourself

You don't need to trust us \u2014 you can audit us.

  1. Confirm our 501(c)(3) status: Search EIN 92-2997844 on IRS Tax-Exempt Organization Search.
  2. Confirm FDA clearance K040187: Search the device on FDA 510(k) Database.
  3. Verify any PMID: Click through to NCBI PubMed and confirm the article title matches the claim.
  4. Audit our source code: The structured registries are at lib/*-registry.ts on GitHub. Every condition, compound, trial, and biography is plain-text auditable.
  5. Review our changelog: Every significant content change is logged with PR reference on the public changelog page.

When ASH won't claim authority

ASH publishes institutional reference content. We are explicitly NOT:

  • A medical board (we don't license clinicians)
  • A certification body (we don't certify hirudotherapists)
  • A treatment recommendation source (we don't tell you to undergo therapy)
  • A drug or device manufacturer (we have no commercial product)
  • A regulatory authority (FDA, EMA, MHRA, etc. remain the legal channels)

We are an open-knowledge organization that catalogs and verifies clinical and scientific information. Clinical decisions belong to you and your clinician.

Report an issue

If you spot an error \u2014 factual, medical, regulatory, or otherwise \u2014 we want to know. Errors will be corrected publicly with a changelog entry.

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.

Transparency & Trust — ASH | American Society of Hirudotherapy